Table 1.
Clinical characteristics of 1096 samples according to PGK1 low or high expression
Characteristics | PGK1 | ||
---|---|---|---|
Low expression | High expression | P-value | |
Age | 57.84 ± 12.81 | 58.77 ± 13.57 | 0.243 |
T stage | 0.002 | ||
T1 | 156 | 124 | |
T2 | 304 | 331 | |
T3 | 77 | 62 | |
T4 | 10 | 29 | |
Tx | 1 | 2 | |
N stage | 0.047 | ||
N0 | 270 | 247 | |
N1 | 187 | 176 | |
N2 | 44 | 75 | |
N3 | 38 | 39 | |
Nx | 9 | 11 | |
M stage | 0.007 | ||
M0 | 453 | 457 | |
M1 | 4 | 17 | |
Mx | 91 | 74 | |
Tumor stage (AJCC 8th version) | 0.001 | ||
Stage I | 110 | 72 | |
Stage II | 309 | 315 | |
Stage III | 117 | 131 | |
Stage IV | 3 | 16 | |
Stage X | 6 | 6 | |
NA | 3 | 8 | |
ER status | < 0.001 | ||
Positive | 461 | 345 | |
Negative | 64 | 176 | |
NA | 23 | 27 | |
PR status | < 0.001 | ||
Positive | 410 | 288 | |
Negative | 113 | 232 | |
NA | 25 | 28 | |
Her2 status | < 0.001 | ||
Positive | 50 | 111 | |
Negative | 288 | 276 | |
NA | 210 | 161 | |
Overall survival | < 0.001 | ||
Alive | 495 | 453 | |
Dead | 53 | 95 |